 Connection
Martin McCarter to Esophagogastric Junction
This is a "connection" page, showing publications Martin McCarter has written about Esophagogastric Junction.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.430 |
|
|
|
-
Ho F, Torphy RJ, Friedman C, Leong S, Kim S, Wani S, Schefter T, Scott CD, Mitchell JD, Weyant MJ, Meguid RA, Gleisner AL, Goodman KA, McCarter MD. Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2021 Nov; 28(12):7208-7218.
Score: 0.175
-
Torphy RJ, Ho F, McCarter MD. ASO Author Reflections: Revisiting the Role of Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2021 10; 28(11):6058-6059.
Score: 0.175
-
Yee EJ, Read J, Ziogas IA, Stuart CM, Olsen J, Kim SS, Mitchell JD, Meguid RA, McCarter MD, Mungo B. More May Not Be Better: Comparison of Oncologic Outcomes Following Induction Chemotherapy Plus Chemoradiation and Chemoradiation Alone for Esophageal Adenocarcinoma. J Surg Oncol. 2025 Mar; 131(4):598-606.
Score: 0.056
-
Merkow RP, Bilimoria KY, McCarter MD, Phillips JD, DeCamp MM, Sherman KL, Ko CY, Bentrem DJ. Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation. Arch Surg. 2012 Nov; 147(11):1009-16.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|